Variant report
Variant | esv3496163 |
---|---|
Chromosome Location | chr8:20782372-20785870 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549568059 | chr8:20782389-20782390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371324566 | chr8:20782401-20782402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568174000 | chr8:20782534-20782535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535158945 | chr8:20782545-20782546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553829557 | chr8:20782563-20782564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73629658 | chr8:20782580-20782581 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs539396015 | chr8:20782591-20782592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557649262 | chr8:20782614-20782615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575895383 | chr8:20782616-20782617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543222148 | chr8:20782633-20782634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145407211 | chr8:20782661-20782662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573776158 | chr8:20782676-20782677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34177244 | chr8:20782677-20782678 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs559783699 | chr8:20782698-20782699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188213519 | chr8:20782802-20782803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545359111 | chr8:20782820-20782821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563986771 | chr8:20782822-20782823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181114493 | chr8:20782846-20782847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146485977 | chr8:20782859-20782860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567908244 | chr8:20782862-20782863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185607716 | chr8:20782868-20782869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61446707 | chr8:20782900-20782901 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs35173151 | chr8:20782914-20782915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539075764 | chr8:20782970-20782971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557287494 | chr8:20782974-20782975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374152235 | chr8:20782995-20782996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140761224 | chr8:20783003-20783004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544913103 | chr8:20783057-20783058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150110856 | chr8:20783105-20783106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573789283 | chr8:20783111-20783112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541199137 | chr8:20783134-20783135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570180211 | chr8:20783188-20783189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563125803 | chr8:20783215-20783216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553213690 | chr8:20783230-20783231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs578020180 | chr8:20783270-20783271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181910991 | chr8:20783306-20783307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7814874 | chr8:20783310-20783311 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs186987056 | chr8:20783342-20783343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549109232 | chr8:20783357-20783358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538983547 | chr8:20783359-20783360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543385442 | chr8:20783360-20783361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561602840 | chr8:20783396-20783397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528698490 | chr8:20783425-20783426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7836543 | chr8:20783432-20783433 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs13268299 | chr8:20783447-20783448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532996642 | chr8:20783472-20783473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551057810 | chr8:20783492-20783493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569351515 | chr8:20783495-20783496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536632431 | chr8:20783504-20783505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs548895305 | chr8:20783507-20783508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20781600-20782400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr8:20781800-20782400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr8:20782400-20785400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr8:20782400-20785400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr8:20785400-20786600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr8:20785400-20786800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr8:20785600-20786400 | Enhancers | Primary hematopoietic stem cells | blood |
8 | chr8:20785800-20786200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |